Cosmos Other Stockholder Equity from 2010 to 2024

COSM Stock  USD 0.79  0.01  1.25%   
Cosmos Health Other Stockholder Equity yearly trend continues to be very stable with very little volatility. Other Stockholder Equity is likely to grow to about 128.8 M this year. During the period from 2010 to 2024, Cosmos Health Other Stockholder Equity quarterly data regression pattern had sample variance of 2274 T and median of  5,556,547. View All Fundamentals
 
Other Stockholder Equity  
First Reported
2009-12-31
Previous Quarter
129.4 M
Current Value
139.9 M
Quarterly Volatility
36.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cosmos Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cosmos Health's main balance sheet or income statement drivers, such as Interest Expense of 1.6 M, Selling General Administrative of 26.8 M or Other Operating Expenses of 69.8 M, as well as many indicators such as Price To Sales Ratio of 0.3, Dividend Yield of 3.44 or PTB Ratio of 0.49. Cosmos financial statements analysis is a perfect complement when working with Cosmos Health Valuation or Volatility modules.
  
Check out the analysis of Cosmos Health Correlation against competitors.
To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.

Latest Cosmos Health's Other Stockholder Equity Growth Pattern

Below is the plot of the Other Stockholder Equity of Cosmos Health over the last few years. It is Cosmos Health's Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cosmos Health's overall financial position and show how it may be relating to other accounts over time.
Other Stockholder Equity10 Years Trend
Slightly volatile
   Other Stockholder Equity   
       Timeline  

Cosmos Other Stockholder Equity Regression Statistics

Arithmetic Mean29,708,983
Geometric Mean3,027,284
Coefficient Of Variation160.51
Mean Deviation37,075,202
Median5,556,547
Standard Deviation47,686,726
Sample Variance2274T
Range129.2M
R-Value0.80
Mean Square Error886T
R-Squared0.64
Significance0.0004
Slope8,518,548
Total Sum of Squares31836.3T

Cosmos Other Stockholder Equity History

2024128.8 M
2023122.6 M
2022106.6 M
202138.9 M
202013.7 M
201913.1 M
201812.9 M

About Cosmos Health Financial Statements

Cosmos Health investors utilize fundamental indicators, such as Other Stockholder Equity, to predict how Cosmos Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Other Stockholder Equity122.6 M128.8 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Cosmos Health is a strong investment it is important to analyze Cosmos Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cosmos Health's future performance. For an informed investment choice regarding Cosmos Stock, refer to the following important reports:
Check out the analysis of Cosmos Health Correlation against competitors.
To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cosmos Health. If investors know Cosmos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cosmos Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.45)
Revenue Per Share
3.733
Quarterly Revenue Growth
0.068
Return On Assets
(0.20)
Return On Equity
(0.57)
The market value of Cosmos Health is measured differently than its book value, which is the value of Cosmos that is recorded on the company's balance sheet. Investors also form their own opinion of Cosmos Health's value that differs from its market value or its book value, called intrinsic value, which is Cosmos Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cosmos Health's market value can be influenced by many factors that don't directly affect Cosmos Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cosmos Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cosmos Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cosmos Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.